We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
Comment analyzes cardiac adverse events related to sorafenib in Japan, highlighting potential safety concerns.
No takes yet. Share an insight, caveat, or question.
A 2025 study studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: